TrademarkDir
GALILEO
LIVE

Serial Number

85044988

Owner

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC.

Attorney

Troy E. Larson

First Use Date

Aug 16, 2010

Filing Date

May 21, 2010

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

GALILEO Trademark

Serial Number: 85044988 • Registration: 4000874

GALILEO is a trademark filed by EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. on May 21, 2010. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

EXPRESS SCRIPTS STRATEGIC DEVELOPMENT, INC. (287 trademarks)

ONE EXPRESS WAY
ST. LOUIS, MO 63121

Entity Type: 03

CURASCRIPT, INC. (57 trademarks)

6272 LEE VISTA BOULEVARD
ORLANDA, FL 32822

Entity Type: 03

Trademark Details

Filing Date

May 21, 2010

Registration Date

July 26, 2011

First Use Anywhere

August 16, 2010

First Use in Commerce

August 16, 2010

Published for Opposition

May 10, 2011

Goods & Services

Computer services, namely, providing a web-based system and on-line portal that enables users to access business intelligence in the field of pharmaceuticals, namely, for accessing, reporting and analyzing pharmaceutical inventories, usage, and sales, and for accessing, reporting, and analyzing business data about specialty pharmaceuticals; computer services, namely, providing a web-based system and online portal featuring on-line non-downloadable software that enables users to access information and materials in the field of specialty pharmaceuticals

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Aug 5, 2021 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 5, 2021 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 5, 2021 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Aug 3, 2021 APRE
TEAS SECTION 8 & 9 RECEIVED
Apr 20, 2021 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 26, 2020 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 4, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 4, 2019 REAP
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jul 26, 2017 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 26, 2017 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jul 26, 2017 APRE
TEAS SECTION 8 & 15 RECEIVED
Jun 7, 2017 E815
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
May 3, 2017 ASGN
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 26, 2016 REM1
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 23, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 23, 2012 REAP
REGISTERED-PRINCIPAL REGISTER
Jul 26, 2011 R.PR
PUBLISHED FOR OPPOSITION
May 10, 2011 PUBO
NOTICE OF PUBLICATION
Apr 20, 2011 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 2, 2011 PREV
ASSIGNED TO LIE
Apr 2, 2011 ALIE
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE MAILED
Mar 22, 2011 AAUA
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 19, 2011 CNSA
USE AMENDMENT ACCEPTED
Mar 19, 2011 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Mar 19, 2011 AUPC
USE AMENDMENT FILED
Mar 19, 2011 IUAF
TEAS AMENDMENT OF USE RECEIVED
Mar 18, 2011 EAAU
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 18, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 18, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 18, 2011 TROA
PRIORITY ACTION MAILED
Feb 11, 2011 CPRA
PRIORITY ACTION WRITTEN
Feb 10, 2011 CPRA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 7, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 6, 2011 TROA
NON-FINAL ACTION MAILED
Sep 9, 2010 CNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2010 CNRT
ASSIGNED TO EXAMINER
Sep 3, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 26, 2010 NWOS
NEW APPLICATION ENTERED
May 25, 2010 NWAP

Related Trademarks

More from this Owner

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EVERNORTH INTELLISPHERE

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

EXPRESS SCRIPTS PHARMACY CLEARCHOICE PRICING

ONCOLOGY CARE VALUE

ONCOLOGY CARE VALUE